Scientists were stunned after a recent groundbreaking discovery deep beneath the Bermuda Triangle, which is located between Florida, Puerto Rico and Bermuda - a section of the Atlantic Ocean infamous ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X The film, which hit theaters on Wednesday, November 26, centers on an afterlife where souls are ...

Elizabeth Olsen’s character Joan finds herself in an afterlife love triangle with her first and second husband in her new film, Eternity — but who does she choose to spend forever with? Warning: ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...